No Detail Found!

Alkaline Phosphatase: A Prognostic Biomarker in Non-Metastatic Colon Adenocarcinoma Patients - A Single-Centre Study

Author(s)
Aminuddin Sheikh Departmen of Pathology, Hamdard College of Medicine and Dentistry, Hamdard University, Karachi, Pakistan
Syed Amir Maqbool Department of Oncology, Karachi Institute of Radiotherapy and Nuclear Medicine, Karachi, Pakistan
Uzma Raza Department of Biochemistry, Hamdard College of Medicine and Dentistry, Hamdard University, Karachi, Pakistan
Mahay Rookh Asif Department of Pharmacology, Hamdard College of Medicine and Dentistry, Hamdard University, Karachi, Pakistan
Fatima Rizvi Department of Pharmacology, Dow International Medical College, Karachi, Pakistan
Uzma Bukhari Department of Pathology, Dow International Medical College, Ojha Campus, Karachi, Pakistan
Abstract
Objective: To determine the prognostic signi cance of liver enzymes in colon carcinoma occurrence in country lifestyle and treatment follow-ups and to correlate them with tumour histopathology. Study Design: A cross-sectional study. Place and Duration of the Study: Department of Oncology, Karachi Institute of Radiotherapy and Nuclear Medicine, Karachi, Pakistan, from May 2023 to July 2024. Methodology: Two hundred non-metastatic colon cancer patients with adenocarcinoma were selected from all provinces and compared with one hundred control subjects. Histopathological patients were grouped based on tumour grade and location. Treatment grouping was according to the prescribed chemotherapy FOLFOX-6 (n = 59), FOLFIRI (n = 82), and FOLFIRI + Bevacizumab (n = 59). Liver enzymes (alkaline phosphatase, alanine transaminase) and CEA colon were estimated by SPSS version 23. ANOVA was used for continuous variable comparison. Results: Alanine transaminase (ALT) and Alkaline phosphatase (ALP) levels were signi cantly elevated in patients across all tumour grades before treatment (p <0.05). A progressive signi cant decrease in ALP and carcinoembryonic antigen (CEA) levels was observed in resectable carcinoma patients on chemotherapy across all treatment groups (p <0.05). FOLFOX and FOLFIRI signi cantly decreased ALT levels in well and moderately di erentiated carcinoma patients (p <0.05), whereas adding bevacizumab to FOLFIRI decreased ALT levels in poorly di erentiated carcinoma patients, depending on tumour location (p <0.05). ALP levels correlate with symptom duration (p <0.05). Lifestyle was found associated with tumour histological grade. Conclusion: A signi cant increase in ALP levels with symptom duration and decrease with treatment progress, identi es its signi cance as a prognostic marker in non-metastatic colon adenocarcinoma patients. Country lifestyle plays a role in colon adenocarcinoma occurrence.
Publication Details
Page(s) 185-190
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Bevacizumab, alkaline phosphatase, Alanine transaminase, Prognostic marker, Colonic neoplasm
References
Alzahrani SM,Al Doghaither HA,Al-Ghafari AB HA,mco HA .2021 .General insight into cancer: An overview of colorectal cancer. Mol Clin Oncol, 2433(6) : 271.
Jiang T,Zeng Q,He J .2023 .Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumours. Transl Cancer Res, 10(10) : 2932-45.
Lakemeyer L,Sander S,Wittau M,Bruns DH,Kornmann M,Lemke J .2021 .Diagnostic and prognostic value of CEA and CA19-9 in colorectal cancer. Diseases, 10(1) : 21.
Jo H,Lee MS,Lee YP,Kim H,Hong JY,Lee J .2022 .A comparison of folinic acid, uorouracil and irinotecan (FOLFIRI) plus bevacizumab and FOLFIRI plus a ibercept as second-line treatment for metastatic colorectal cancer. Clin Oncol; 34, 02(8) : e323-8.
Marino P,Mininni M,Deiana G,Marino G,Divella R,Bochicchio I .2024 .Healthy lifestyle and cancer risk: modi able risk factors to prevent cancerN. utrients, 10(6) : 800.
Slaoui M .2011 .Histopathology procedures: From tissue sampling to histopathological evaluation. Methods Mol Biol, 10(2) : 4-82.
Arole V,Chen W. .2024 .Staging-carcinoma. Pathology outlines.com website. html (Accessed on: June 20, : .
.2024 .-rectal-cancer/ detection-diagnosis-staging/staged. html (Accessed on: June 20, : .
Benson AB,Venook AP,Adam M,Chang G,Chen YJ,Ciombor KK .2024 .:e240029. J Natl Compr Canc Netw 2024, 0029(2D) : .
Pectasides D,Karavasilis V,Papaxoinis G,Gourgioti G,Makatssories T,Raptou G .2015 .Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5- uorouracil, leucovorin and oxaliplatin (modi ed FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer. BMC Cancer, 10 : 384.
Cutsem EV,Tabernero J,Lakomy R,Prenen H,Prausova J,Macarulla T .2012 .Addition of a ibercept to uorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J Clin Oncol, 42(28) : 3499-506.
Zhao Z,Pelletier E,Barber B,Bhosle M,Wang S,Gao S .2011 .Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe. Curr Med Res Opin, 650503(2) : 221-9.
Bergmeyer HU,Horder M,Rej R .1986 .) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (Lalanine: 2-oxoglutarate aminotransferase. J Clin Chem Clin Biochem, 24(7) : 481-95.
Tietz NW,Burtis CA,Duncan P,Ervin K,Petitclerc CJ,Rinker AD .1983 .A reference method for measurement of alkaline phosphatase activity in human serum. Clin Chem, 29(5) : 751-61.
Liaison(R) Cea .2018 .Ref) 314311. , : .
Argota IB,Montana R,Javier F,Ballabrera FS,Rodriguez AG,Castells MR .2024 .Sex and gender perspectives in colorectal cancer. / (Accessed on November 25, : .
Putri A,Imran Y. .2021 .Review of the e ect of sedentary behaviour and BMI on cognitive decline in young adults. 2022 Dec, 10 : 157-6.
Rifkin SB,Miller AK,Sanchez EEM,Norwood DA,Martinez E,Waterboer T .2023 .Wood cookstove use is associated with gastric cancer in Central America and mediated by host genetics. Sci Rep, 10(1) : 16515.
Celiberto F,Aloisio A,Girardi B,Pricci M,Iannone A,Russo F .2023 .Fibres and colorectal cancer: Clinical and molecular evidence. Int J Mol Sci, 24(17) : .
He MM,Fang Z,Hang D,Wang F,Polychronidis G,Wang L .2021 .Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank. Int J Cancer, 10(8) : 1867-78.
Neugut AI,Lin A,Raab GT,Hillyer GC,Keller D,O'Neil DS .2019 .FOLFOX and FOLFIRI use in stage IV colon cancer: Analysis of seer-medicare data. Clin Colorectal Cancer, 01(2) : 133-40.
0

Citations

0

Downloads

171

Views